HENDERSON MOLLY (CFO and CBO) sold 1.3% of their position (1.29K shares) of PHATHOM PHARMACEUTICALS, INC. on the open market
Open‑market sale worth $10.3K — a minor trim. Review remaining holdings and any 10b5‑1 plan disclosures.
S · 1 sale
Filed: 12/20/2024ACC: 0000950170-24-139062
Officer· CFO and CBO
Since Apr 2022
-1.29K
Net shares
Net seller
$10.3K
Total sold
1
Open market trades
0B · 1S
1
Total transactions
1.29K disposed
Non-Derivative Transactions1
Common Stock
Direct
Shares
−1.29K
Price / share
$8.00
Trade value
$10.33K
% of position
1.3%
12/19/2024
99.45K→98.16K
Total
Net shares
−1.29K
Net value
-$10.33K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 12/19/2024 | S · Sale | −1.29K | $8.00 | $10.33K | 1.3% | 99.45K | 98.16K |
| Total | −1.29K | -$10.33K | ||||||
Derivative Transactions0
No derivative transactions reported
Non-Derivative Holdings (Post-Transaction)1
Common Stock
IndirectShares owned1.91K
Total
1.91K indirect1.91K
| Security Title | Shares Owned | Ownership Type |
|---|---|---|
| Common Stock | 1.91K | Indirect |
| Total | 1.91K | 1.91K indirect |
Derivative Holdings (Post-Transaction)0
No derivative holdings reported